These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 7838793)
1. Adenosine induced torsades de pointes in a child with congenital long QT syndrome. Celiker A; Tokel K; Cil E; Ozkutlu S; Ozme S Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 1):1814-7. PubMed ID: 7838793 [TBL] [Abstract][Full Text] [Related]
2. Cocaine-induced torsades de pointes in idiopathic long Q-T syndrome. Singh N; Singh HK; Singh PP; Khan IA Am J Ther; 2001; 8(4):299-302. PubMed ID: 11441329 [TBL] [Abstract][Full Text] [Related]
3. Torsades de pointes: a case with multiple variables. Khan IA; Win MT; Bali AJ; Vasavada BC; Sacchi TJ Am J Emerg Med; 1999 Jan; 17(1):80-5. PubMed ID: 9928709 [TBL] [Abstract][Full Text] [Related]
4. Acquired long QT syndrome and torsade de pointes. El-Sherif N; Turitto G; Boutjdir M Pacing Clin Electrophysiol; 2018 Apr; 41(4):414-421. PubMed ID: 29405316 [TBL] [Abstract][Full Text] [Related]
5. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome. Johansson M; Carlsson L J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331 [TBL] [Abstract][Full Text] [Related]
6. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases. Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140 [TBL] [Abstract][Full Text] [Related]
7. Torsades de pointes after adenosine administration. Teodorovich N; Margolin E; Kogan Y; Paz O; Swissa M J Electrocardiol; 2016; 49(2):171-3. PubMed ID: 26850499 [TBL] [Abstract][Full Text] [Related]
8. Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function. Da Costa A; Chalvidan T; Belounas A; Messier M; Viallet M; Mansour H; Lamaison D; Djiane P; Isaaz K J Cardiovasc Electrophysiol; 2000 Sep; 11(9):990-7. PubMed ID: 11021469 [TBL] [Abstract][Full Text] [Related]
9. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes. Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280 [TBL] [Abstract][Full Text] [Related]
10. A practical approach to torsade de pointes. Roden DM Clin Cardiol; 1997 Mar; 20(3):285-90. PubMed ID: 9068917 [TBL] [Abstract][Full Text] [Related]
11. Apparent ventricular bigeminy in the congenital long QT syndrome: what is the mechanism? Liu YB; Chen WJ; Lee YT J Cardiovasc Electrophysiol; 2000 Mar; 11(3):371-2. PubMed ID: 10749362 [No Abstract] [Full Text] [Related]
12. Congenital long QT syndrome: severe torsades de pointes provoked by epinephrine in a digenic mutation carrier. Tan VH; Duff H; Kuriachan V; Gerull B Heart Lung; 2014; 43(6):541-5. PubMed ID: 25236808 [TBL] [Abstract][Full Text] [Related]
13. Mode of onset of torsade de pointes in congenital long QT syndrome. Viskin S; Alla SR; Barron HV; Heller K; Saxon L; Kitzis I; Hare GF; Wong MJ; Lesh MD; Scheinman MM J Am Coll Cardiol; 1996 Nov; 28(5):1262-8. PubMed ID: 8890825 [TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis and in utero treatment of torsades de pointes associated with congenital long QT syndrome. Cuneo BF; Ovadia M; Strasburger JF; Zhao H; Petropulos T; Schneider J; Wakai RT Am J Cardiol; 2003 Jun; 91(11):1395-8. PubMed ID: 12767447 [No Abstract] [Full Text] [Related]
15. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block. Cho MS; Nam GB; Kim YG; Hwang KW; Kim YR; Choi H; Kim SH; Rhee KS; Kim NJ; Kim JS; Kim J; Choi KJ; Kim YH Heart Rhythm; 2015 Mar; 12(3):498-505. PubMed ID: 25460857 [TBL] [Abstract][Full Text] [Related]
16. Induction of torsades de pointes by dobutamine infusion in a patient with idiopathic long QT syndrome. Fujikawa H; Sato Y; Arakawa H; Mitsuhashi T; Minezaki K; Kuroki S; Sekiguchi H; Nakayama T; Ikeda U; Shimada K Intern Med; 1998 Feb; 37(2):149-52. PubMed ID: 9550594 [TBL] [Abstract][Full Text] [Related]
17. Early afterdepolarizationlike activity in patients with class IA induced long QT syndrome and torsades de pointes. Kurita T; Ohe T; Shimizu W; Suyama K; Aihara N; Takaki H; Kamakura S; Shimomura K Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):695-705. PubMed ID: 9080496 [TBL] [Abstract][Full Text] [Related]
18. Fluconazole-associated QT interval prolongation and Torsades de Pointes in a paediatric patient. Ünal Yüksekgönül A; Ertuğrul İ; Karagöz T Cardiol Young; 2021 Dec; 31(12):2035-2037. PubMed ID: 34024302 [TBL] [Abstract][Full Text] [Related]
19. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization. Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502 [TBL] [Abstract][Full Text] [Related]
20. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. Kirchhof P; Franz MR; Bardai A; Wilde AM J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]